Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - microfluidics
Microfluidic device for large-scale production of lipid nanoparticles
A scalable, parallelized, multi-channel microfluidic device for generating lipid nanoparticles. Problem: Lipid nanoparticles are a promising delivery technology for RNA therapeutics and vaccines. However, there is a lack of formulation strategies that can produce nanoparticles with precisely defined properties that have scalable throughputs ranging...
Therapeutics & Vaccines
Rapid and ultrasensitive SARS-CoV-2 antigen detection for acute COVID-19 screening in community settings
rss.brief>A portable point-of-care device for rapid and sensitive detection of acute SARS-CoV-2 infections. Problem: The COVID-19 pandemic has infected over 40 million people worldwide as of mid-October 2020, causing more than 1 million deaths. Up to 50-80% of transmissions occur from asymptomatic patients. Current tests can have a turnaround time...
Rapid plasma separator for point-of-care diagnostics and viral load detection that does not require electrical power
Membrane-based, sedimentation-assisted plasma separator from whole blood for clinical tests Problem: High sensitivity, point-of-care clinical tests, such as HIV load, require large volumes of plasma. Centrifugation is widely used for separating plasma from whole blood, but it is not always accessible and can be a limiting factor for point-of-care...
© 2021. All Rights Reserved. Powered by